These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 35921217)

  • 1. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
    Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
    J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation, scaffold hopping of novel donepezil-based compounds as anti-Alzhiemer's agents: synthesis, in-silico and pharmacological evaluations.
    Gupta M; Pant S; Rana P; Kumar A; Prasun C; Nair MS; Paliwal S; Nain S
    Sci Rep; 2024 Jan; 14(1):1687. PubMed ID: 38242995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2D-QSAR, molecular docking and MD simulation based virtual screening of the herbal molecules against Alzheimer's disorder: an approach to predict CNS activity.
    Thakur A; Sharma B; Parashar A; Sharma V; Kumar A; Mehta V
    J Biomol Struct Dyn; 2024; 42(1):148-162. PubMed ID: 36970779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholinesterase inhibition of Alzheimer's disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition.
    Koly HK; Sutradhar K; Rahman MS
    J Biomol Struct Dyn; 2023; 41(22):12532-12544. PubMed ID: 36651199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Benzylated (Pyrrolidin-2-one)/(Imidazolidin-2-one) Derivatives as Potential Anti-Alzheimer's Agents: Synthesis and Pharmacological Investigations.
    Gupta M; Ojha M; Yadav D; Pant S; Yadav R
    ACS Chem Neurosci; 2020 Sep; 11(18):2849-2860. PubMed ID: 32816447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.
    Junaid M; Islam N; Hossain MK; Ullah MO; Halim MA
    PLoS One; 2019; 14(2):e0211935. PubMed ID: 30785927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S; Singh BK
    Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
    Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
    Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of vilazodone-donepezil chimeric derivatives as acetylcholinesterase inhibitors by QSAR, molecular docking and molecular dynamics simulations.
    Guo L; Chang Z; Tong J; Gao P; Zhang Y; Liu Y; Yang Y; Wang C
    Phys Chem Chem Phys; 2024 Jul; 26(26):18149-18161. PubMed ID: 38896464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, Molecular Docking, and Molecular Dynamics Simulation Studies of Novel 3-Hydroxypyridine-4-one Derivatives as Potential Acetylcholinesterase Inhibitors.
    Asgarshamsi MH; Fassihi A; Dehkordi MM
    Chem Biodivers; 2023 Jul; 20(7):e202300325. PubMed ID: 37347200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease.
    El Khatabi K; El-Mernissi R; Aanouz I; Ajana MA; Lakhlifi T; Khan A; Wei DQ; Bouachrine M
    J Mol Model; 2021 Sep; 27(10):302. PubMed ID: 34581863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation and molecular modeling studies of modulated benzyloxychalcones as potential acetylcholinesterase inhibitors.
    Abdalla Ali A; Mhamad SA; Hasan AH; Ahmad I; Abdullah SA; Jamil S; Patel H; Murugesan S; Jamalis J
    J Biomol Struct Dyn; 2024 Apr; 42(7):3604-3615. PubMed ID: 37293930
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Chintha N; Jupudi S; Palathoti N; Bharathi J J; Justin A
    J Biomol Struct Dyn; 2023; 41(22):12620-12631. PubMed ID: 36644856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer's disease.
    Rodríguez-Lavado J; Gallardo-Garrido C; Mallea M; Bustos V; Osorio R; Hödar-Salazar M; Chung H; Araya-Maturana R; Lorca M; Pessoa-Mahana CD; Mella-Raipán J; Saitz C; Jaque P; Reyes-Parada M; Iturriaga-Vásquez P; Pessoa-Mahana H
    Eur J Med Chem; 2020 Jul; 198():112368. PubMed ID: 32388114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and identification of secondary metabolites in the bark of
    Khare N; Maheshwari SK; Jha AK
    J Biomol Struct Dyn; 2021 Oct; 39(16):5988-5998. PubMed ID: 32720564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New azole-derived hemiaminal ethers as promising acetylcholinesterase inhibitors: synthesis, X-ray structures,
    Nisar M; Gondal HY; Cheema ZM; Yousaf S; Nadeem H
    J Biomol Struct Dyn; 2023; 41(24):15535-15548. PubMed ID: 37021341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.